Insider Trading activities of Alnylam Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alnylam Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alnylam Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Alnylam Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ALNY. The reporting company's CIK number is 1178670.
The total value of stock buying since 2005 is $1,972,189,983.
The total value of stock sales since 2005 is $300,938,573.
The total value of stock option exercises since 2005 is $52,704,758.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Alnylam Pharmaceuticals, Inc. (ALNY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-11 0 $0 0 $0 98,636 $2,105,878
2018-08 0 $0 2,500 $300,000 0 $0
2018-07 0 $0 50,000 $5,231,100 50,000 $1,067,500
2018-06 0 $0 1,563 $164,177 1,563 $65,989
2018-05 0 $0 15,000 $1,511,430 15,000 $409,200
2018-03 0 $0 230,737 $33,207,736 192,277 $6,368,074
2018-01 0 $0 36,745 $4,872,460 31,781 $2,559,323
2017-12 0 $0 36,249 $4,824,343 49,338 $2,918,013
2017-11 0 $0 167,415 $21,714,542 167,415 $5,229,156
2017-10 0 $0 118,982 $14,746,940 118,982 $2,540,265
2017-09 0 $0 76,815 $7,681,500 88,659 $2,563,772
2017-06 0 $0 0 $0 1,668 $33,368
2017-05 309,001 $22,132,898 64,125 $4,325,000 64,125 $1,509,287
2017-02 0 $0 25,000 $998,500 25,000 $782,250
2017-01 0 $0 30,000 $1,137,525 31,340 $734,504
2016-12 0 $0 0 $0 39,698 $865,542
2016-11 0 $0 29,165 $1,322,457 29,165 $663,503
2016-10 27,900 $1,032,327 0 $0 7,540 $97,115
2016-07 0 $0 30,151 $1,951,145 30,151 $685,935
2016-04 0 $0 30,151 $2,046,031 30,151 $685,935
2016-03 2,000 $116,720 0 $0 16,540 $134,304
2016-02 205,030 $14,300,842 0 $0 0 $0
2016-01 0 $0 30,152 $2,185,869 30,152 $685,958
2015-12 0 $0 88,689 $9,431,523 88,689 $1,201,849
2015-11 0 $0 133,690 $13,885,117 150,004 $1,708,673
2015-08 0 $0 0 $0 26,972 $513,277
2015-06 0 $0 13,541 $1,764,877 13,541 $311,276
2015-05 2,000 $224,320 67,379 $8,422,375 67,379 $884,012
2015-04 0 $0 18,165 $2,361,813 10,000 $286,850
2015-03 0 $0 24,456 $2,907,600 19,456 $389,634
2015-01 951,817 $1,900,249,337 0 $0 0 $0
2014-12 0 $0 73,988 $7,502,606 87,456 $1,469,670
2014-11 0 $0 59,300 $5,540,674 59,300 $558,234
2014-10 0 $0 130,000 $11,225,000 130,000 $1,205,850
2014-09 0 $0 214,293 $16,620,760 214,293 $2,374,463
2014-08 0 $0 13,500 $908,793 13,500 $109,619
2014-06 0 $0 124,293 $8,222,933 124,293 $939,548
2014-05 0 $0 162,168 $9,159,911 162,168 $1,340,090
2014-04 0 $0 0 $0 28,707 $546,294
2014-03 344,448 $23,036,682 32,769 $2,431,230 32,769 $315,401
2014-02 0 $0 24,150 $1,932,871 79,331 $602,191
2014-01 0 $0 22,890 $1,959,705 15,000 $237,300
2013-12 0 $0 60,230 $3,725,153 75,182 $797,164
2013-11 0 $0 13,500 $720,306 13,500 $215,865
2013-10 0 $0 15,000 $900,000 27,665 $225,368
2013-09 0 $0 65,197 $3,677,272 65,197 $114,124
2013-08 0 $0 60,000 $2,935,140 60,000 $57,000
2013-07 0 $0 101,200 $3,800,840 101,200 $1,098,088
2013-06 0 $0 38,625 $1,175,782 38,625 $415,518
2013-05 0 $0 27,822 $834,660 27,822 $57,180
2013-03 0 $0 106,939 $2,577,275 106,939 $153,779
2013-02 0 $0 63,503 $1,498,916 5,000 $35,500
2013-01 4,967 $99,985 0 $0 0 $0
2012-12 0 $0 17,177 $312,105 35,794 $151,999
2012-11 0 $0 6,573 $111,544 6,573 $46,668
2012-09 0 $0 1,558,146 $30,256,570 6,250 $58,124
2012-07 0 $0 57,795 $1,096,707 57,795 $573,083
2012-02 120,696 $1,297,480 0 $0 0 $0
2012-01 1,701 $14,986 0 $0 0 $0
2011-12 2,096 $14,990 0 $0 0 $0
2011-11 2,115 $14,990 0 $0 0 $0
2011-10 2,222 $14,983 0 $0 0 $0
2010-08 0 $0 0 $0 50,000 $23,750
2010-06 0 $0 85,000 $1,343,277 75,000 $526,499
2010-04 55,223 $993,461 0 $0 0 $0
2009-09 0 $0 75,000 $1,657,703 0 $0
2009-06 0 $0 120,000 $2,582,280 120,000 $57,000
2009-05 65,922 $1,153,635 0 $0 0 $0
2009-04 0 $0 25,000 $440,725 25,000 $23,750
2008-08 0 $0 110,440 $3,758,859 106,639 $65,324
2008-06 0 $0 0 $0 3,000 $1,425
2008-05 213,888 $5,409,227 0 $0 0 $0
2007-12 0 $0 18,778 $607,426 0 $0
2007-11 0 $0 37,222 $1,245,187 20,000 $218,200
2007-10 0 $0 103,590 $3,239,122 20,000 $19,000
2007-06 0 $0 113,847 $1,803,855 75,000 $35,624
2006-10 0 $0 12,500 $258,875 0 $0
2006-05 0 $0 112,583 $1,712,692 75,000 $35,624
2006-03 0 $0 400,882 $6,667,406 0 $0
2006-02 0 $0 616,049 $9,500,353 0 $0
2006-01 100,000 $1,300,000 0 $0 0 $0
2004-05 130,520 $783,120 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Alnylam Pharmaceuticals, Inc. insiders (ALNY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-11-21 Maraganore John (Chief Executive Officer) Option Ex 98,636 21.35 2,105,878
2018-08-30 Greenstreet Yvonne (EVP, Chief Operating Officer) Sale 2,500 120.00 300,000
2018-07-25 Maraganore John (Chief Executive Officer) Sale 50,000 104.62 5,231,100
2018-07-25 Maraganore John (Chief Executive Officer) Option Ex 50,000 21.35 1,067,500
2018-06-20 Keating Laurie (SVP, GC & Secretary) Sale 1,563 105.04 164,177
2018-06-20 Keating Laurie (SVP, GC & Secretary) Option Ex 1,563 42.22 65,989
2018-05-31 Clarke John K (Director) Sale 15,000 100.76 1,511,430
2018-05-31 Clarke John K (Director) Option Ex 15,000 27.28 409,200
2018-03-26 Greenstreet Yvonne (EVP, Chief Operating Officer) Sale 7,221 138.09 997,111
2018-03-26 Greenstreet Yvonne (EVP, Chief Operating Officer) Option Ex 7,221 42.22 304,870
2018-03-20 Keating Laurie (SVP, GC & Secretary) Sale 1,562 149.68 233,797
2018-03-20 Keating Laurie (SVP, GC & Secretary) Option Ex 1,562 42.22 65,947
2018-03-14 Vaishnaw Akshay (President, R&D) Sale 88,554 143.00 12,662,779
2018-03-14 Vaishnaw Akshay (President, R&D) Option Ex 88,554 14.06 1,245,334
2018-03-14 Greene Barry E (President) Sale 38,460 143.09 5,503,049
2018-03-13 Keating Laurie (SVP, GC & Secretary) Sale 10,000 150.00 1,500,000
2018-03-13 Keating Laurie (SVP, GC & Secretary) Option Ex 10,000 77.40 774,000
2018-03-13 Ausiello Dennis A (Director) Sale 17,117 150.00 2,567,550
2018-03-13 Ausiello Dennis A (Director) Option Ex 17,117 61.55 1,053,636
2018-03-13 Schimmel Paul (Director) Sale 27,823 150.00 4,173,450
2018-03-13 Schimmel Paul (Director) Option Ex 27,823 51.07 1,420,837
2018-03-13 Sharp Philip A (Director) Sale 15,000 149.00 2,235,000
2018-03-13 Sharp Philip A (Director) Option Ex 15,000 21.35 320,250
2018-03-12 Keating Laurie (SVP, GC & Secretary) Sale 10,000 140.00 1,400,000
2018-03-12 Keating Laurie (SVP, GC & Secretary) Option Ex 10,000 77.40 774,000
2018-03-09 Sharp Philip A (Director) Sale 15,000 129.00 1,935,000
2018-03-09 Sharp Philip A (Director) Option Ex 15,000 27.28 409,200
2018-01-04 Mason Michael (VP, Finance and Treasurer) Sale 36,745 132.60 4,872,460
2018-01-04 Mason Michael (VP, Finance and Treasurer) Option Ex 31,781 80.53 2,559,323
2017-12-30 Mason Michael (VP, Finance and Treasurer) Option Ex 8,502 .00 0
2017-12-29 Keating Laurie (SVP, GC & Secretary) Option Ex 3,000 77.40 232,200
2017-12-20 Keating Laurie (SVP, GC & Secretary) Sale 6,249 121.70 760,484
2017-12-20 Keating Laurie (SVP, GC & Secretary) Option Ex 6,249 42.22 263,832
2017-12-19 Maraganore John (Chief Executive Officer) Option Ex 1,587 63.00 99,981
2017-12-01 Keating Laurie (SVP, GC and Secretary) Sale 30,000 135.46 4,063,859
2017-12-01 Keating Laurie (SVP, GC and Secretary) Option Ex 30,000 77.40 2,322,000
2017-11-22 Maraganore John (Chief Executive Officer) Sale 73,415 131.35 9,643,060
2017-11-22 Maraganore John (Chief Executive Officer) Option Ex 73,415 31.39 2,304,496
2017-11-15 Maraganore John (Chief Executive Officer) Sale 74,000 127.99 9,471,482
2017-11-15 Maraganore John (Chief Executive Officer) Option Ex 74,000 31.39 2,322,860
2017-11-02 Ausiello Dennis A (Director) Sale 20,000 130.00 2,600,000
2017-11-02 Ausiello Dennis A (Director) Option Ex 20,000 30.09 601,800
2017-10-30 Vaishnaw Akshay (EVP, R&D) Sale 33,666 121.26 4,082,440
2017-10-30 Vaishnaw Akshay (EVP, R&D) Option Ex 33,666 21.35 718,769
2017-10-02 Greene Barry E (President) Sale 85,316 125.00 10,664,500
2017-10-02 Greene Barry E (President) Option Ex 85,316 21.35 1,821,496
2017-09-21 Greene Barry E (President) Option Ex 11,844 12.88 152,550
2017-09-20 Greene Barry E (President) Sale 76,815 100.00 7,681,500
2017-09-20 Greene Barry E (President) Option Ex 76,815 31.39 2,411,222
2017-06-13 Vaishnaw Akshay (EVP, R&D) Option Ex 1,668 20.00 33,368
2017-05-31 Sanofi (10% Owner) Buy 297,501 71.87 21,381,396
2017-05-30 Keating Laurie (SVP, GC and Secretary) Buy 11,500 65.35 751,502
2017-05-23 Vaishnaw Akshay (EVP, R&D) Sale 11,000 75.00 825,000
2017-05-23 Vaishnaw Akshay (EVP, R&D) Option Ex 11,000 21.35 234,850
2017-05-16 Mason Michael (VP, Finance and Treasurer) Sale 9,375 70.00 656,250
2017-05-16 Mason Michael (VP, Finance and Treasurer) Option Ex 9,375 12.88 120,750
2017-05-15 Vaishnaw Akshay (SVP, R&D) Sale 43,750 65.00 2,843,750
2017-05-15 Vaishnaw Akshay (SVP, R&D) Option Ex 43,750 26.37 1,153,687
2017-02-01 Sharp Philip A (Director) Sale 25,000 39.94 998,500
2017-02-01 Sharp Philip A (Director) Option Ex 25,000 31.29 782,250
2017-01-25 Sharp Philip A (Director) Sale 15,000 37.95 569,250
2017-01-25 Sharp Philip A (Director) Option Ex 15,000 31.39 470,850
2017-01-18 Sharp Philip A (Director) Sale 15,000 37.88 568,275
2017-01-18 Sharp Philip A (Director) Option Ex 15,000 15.91 238,650
2017-01-05 Maraganore John (Chief Executive Officer) Option Ex 1,340 18.66 25,004
2016-12-30 Vaishnaw Akshay (EVP, R&D) Option Ex 9,547 18.81 179,607
2016-12-12 Maraganore John (Chief Executive Officer) Option Ex 30,151 22.75 685,935
2016-11-30 Vaishnaw Akshay (EVP, R&D, CMO) Sale 29,165 45.34 1,322,457
2016-11-30 Vaishnaw Akshay (EVP, R&D, CMO) Option Ex 29,165 22.75 663,503
2016-10-13 Pyott David E I (Director) Buy 27,900 37.00 1,032,327
2016-10-12 Maraganore John (Chief Executive Officer) Option Ex 7,540 12.88 97,115
2016-07-20 Maraganore John (CEO) Sale 15,075 65.28 984,141
2016-07-20 Maraganore John (CEO) Option Ex 15,075 22.75 342,956
2016-07-19 Maraganore John (CEO) Sale 15,076 64.14 967,004
2016-07-19 Maraganore John (CEO) Option Ex 15,076 22.75 342,979
2016-04-20 Maraganore John (Chief Executive Officer) Sale 15,075 67.81 1,022,235
2016-04-20 Maraganore John (Chief Executive Officer) Option Ex 15,075 22.75 342,956
2016-04-19 Maraganore John (Chief Executive Officer) Sale 15,076 67.91 1,023,796
2016-04-19 Maraganore John (Chief Executive Officer) Option Ex 15,076 22.75 342,979
2016-03-24 Greene Barry E (President and COO) Option Ex 16,540 8.12 134,304
2016-03-09 Bonney Michael W (Director) Buy 2,000 58.36 116,720
2016-02-01 Sanofi (10% Owner) Buy 205,030 69.75 14,300,842
2016-01-20 Maraganore John (Chief Executive Officer) Sale 15,076 70.50 1,062,903
2016-01-20 Maraganore John (Chief Executive Officer) Option Ex 15,076 22.75 342,979
2016-01-19 Maraganore John (Chief Executive Officer) Sale 15,076 74.49 1,122,966
2016-01-19 Maraganore John (Chief Executive Officer) Option Ex 15,076 22.75 342,979
2015-12-04 Sharp Philip A (Director) Sale 30,000 109.00 3,270,000
2015-12-04 Sharp Philip A (Director) Option Ex 30,000 14.39 431,850
2015-12-02 Maraganore John (Chief Executive Officer) Sale 58,689 104.99 6,161,523
2015-12-02 Maraganore John (Chief Executive Officer) Option Ex 58,689 13.12 769,999
2015-11-25 Vaishnaw Akshay (EVP, R&D, CMO) Option Ex 5,750 19.59 112,642
2015-11-20 Maraganore John (Chief Executive Officer) Sale 58,690 103.14 6,053,580
2015-11-20 Maraganore John (Chief Executive Officer) Option Ex 69,254 10.11 700,157
2015-11-12 Starr Kevin P (Director) Sale 37,500 101.53 3,807,562
2015-11-12 Starr Kevin P (Director) Option Ex 37,500 13.57 509,062
2015-11-11 Starr Kevin P (Director) Sale 37,500 107.31 4,023,975
2015-11-11 Starr Kevin P (Director) Option Ex 37,500 10.31 386,812
2015-08-04 Greene Barry E (President and COO) Option Ex 26,972 19.03 513,277
2015-06-16 Vaishnaw Akshay (EVP, R&D, CMO) Sale 8,750 129.49 1,132,993
2015-06-16 Vaishnaw Akshay (EVP, R&D, CMO) Option Ex 8,750 8.20 71,750
2015-06-01 Mason Michael (VP, Finance and Treasurer) Sale 4,791 131.89 631,884
2015-06-01 Mason Michael (VP, Finance and Treasurer) Option Ex 4,791 49.99 239,526
2015-05-26 Greene Barry E (President and COO) Sale 67,379 125.00 8,422,375
2015-05-26 Greene Barry E (President and COO) Option Ex 67,379 13.12 884,012
2015-05-12 Bonney Michael W (Director) Buy 2,000 112.16 224,320
2015-04-21 Ausiello Dennis A (Director) Sale 8,165 130.02 1,061,613
2015-04-21 Schimmel Paul (Director) Sale 10,000 130.02 1,300,200
2015-04-21 Schimmel Paul (Director) Option Ex 10,000 28.68 286,850
2015-03-19 Ausiello Dennis A (Director) Sale 5,000 120.00 600,000
2015-03-19 Schimmel Paul (Director) Sale 9,053 120.00 1,086,360
2015-03-19 Schimmel Paul (Director) Option Ex 9,053 27.28 246,965
2015-03-17 Vaishnaw Akshay (EVP, R&D, CMO) Sale 8,750 117.30 1,026,410
2015-03-17 Vaishnaw Akshay (EVP, R&D, CMO) Option Ex 8,750 8.20 71,750
2015-03-17 Schimmel Paul (Director) Sale 947 120.00 113,640
2015-03-17 Schimmel Paul (Director) Option Ex 947 27.28 25,834
2015-03-05 Ausiello Dennis A (Director) Sale 706 115.00 81,190
2015-03-05 Ausiello Dennis A (Director) Option Ex 706 63.86 45,085
2015-01-29 Sanofi (10% Owner) Buy 97,118 95.00 9,226,210
2015-01-26 Paul Steven M (Director) Buy 1,000 95.00 95,000
2015-01-26 Maraganore John (Chief Executive Officer) Buy 10,000 95.00 950,000
2015-01-26 Sanofi (10% Owner) Buy 647,448 95.00 61,507,560
2015-01-22 Sanofi (10% Owner) Buy 196,251 9,317.00 1,828,470,567
2014-12-31 Reid Laurence (SVP, Chief Business Officer) Option Ex 17,000 15.99 271,830
2014-12-22 Greene Barry E (President and COO) Option Ex 1,000 13.12 13,120
2014-12-19 Greene Barry E (President and COO) Sale 11,200 100.00 1,120,000
2014-12-16 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 10,626 93.32 991,650
2014-12-16 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 10,626 8.51 90,459
2014-12-15 Mason Michael (VP, Finance and Treasurer) Sale 22,162 99.42 2,203,456
2014-12-15 Mason Michael (VP, Finance and Treasurer) Option Ex 20,625 11.47 236,568
2014-12-15 Maraganore John (Chief Executive Officer) Option Ex 8,205 9.14 74,993
2014-12-08 Ausiello Dennis A (Director) Sale 15,000 107.50 1,612,500
2014-12-08 Ausiello Dennis A (Director) Option Ex 15,000 30.09 451,350
2014-12-08 Schimmel Paul (Director) Sale 15,000 105.00 1,575,000
2014-12-08 Schimmel Paul (Director) Option Ex 15,000 22.09 331,350
2014-11-18 Reid Laurence (SVP, Chief Business Officer) Sale 10,000 91.06 910,570
2014-11-18 Reid Laurence (SVP, Chief Business Officer) Option Ex 10,000 10.74 107,430
2014-11-17 Greene Barry E (President and COO) Sale 33,200 90.97 3,020,104
2014-11-17 Greene Barry E (President and COO) Option Ex 33,200 6.78 225,096
2014-11-11 Ausiello Dennis A (Director) Sale 5,000 100.00 500,000
2014-11-11 Ausiello Dennis A (Director) Option Ex 5,000 30.09 150,450
2014-11-11 Greene Barry E (President and COO) Sale 11,100 100.00 1,110,000
2014-11-11 Greene Barry E (President and COO) Option Ex 11,100 6.78 75,258
2014-10-28 Schimmel Paul (Director) Sale 15,000 95.00 1,425,000
2014-10-28 Schimmel Paul (Director) Option Ex 15,000 15.91 238,650
2014-10-22 Ausiello Dennis A (Director) Sale 5,000 90.00 450,000
2014-10-22 Ausiello Dennis A (Director) Option Ex 5,000 30.09 150,450
2014-10-13 Sharp Philip A (Director) Sale 110,000 85.00 9,350,000
2014-10-13 Sharp Philip A (Director) Option Ex 110,000 7.42 816,750
2014-09-25 Starr Kevin P (Director) Sale 45,000 77.72 3,497,489
2014-09-25 Starr Kevin P (Director) Option Ex 45,000 19.31 868,950
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ALNY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alnylam Pharmaceuticals, Inc. (symbol ALNY, CIK number 1178670) see the Securities and Exchange Commission (SEC) website.